Skip to content
ClinCalc Pro
Menu
Stimulant Laxative

Senna

Brand names: Senokot, Manevac

Senna is a stimulant laxative used in obstetric and gynaecological care for constipation, including pregnancy-related and opioid-induced constipation when bulk-forming measures are insufficient.

Dosing — not shown for this use

The product information we hold does not support a dose for this page's specific use, route or population, so none is shown. Follow your local or national guideline, and confirm against the product SmPC.

The licensed dosing — for the medicine's licensed uses, which may differ from this page's — is on Senna.

Clinical monograph

How it works

Its anthraquinone glycosides are activated by colonic bacteria to stimulate the myenteric plexus, increasing colonic motility and reducing water absorption to promote a bowel movement.

Prescribing in practice

  • It should be avoided where intestinal obstruction is suspected, and prolonged use is discouraged; it may be used in pregnancy when dietary measures and a bulk-forming laxative have not worked.
  • It can cause abdominal cramping and, with overuse, electrolyte disturbance such as hypokalaemia.
  • For opioid-induced constipation, a stimulant laxative such as senna is a rational choice, sometimes combined with a stool softener.

Monitoring

Monitoring is clinical, reviewing bowel response and avoiding prolonged unsupervised use that risks electrolyte imbalance.

Counselling the patient

  • It usually works overnight, so it is often taken at bedtime.
  • Increase fluid and fibre intake alongside the laxative where possible.
  • Stop and seek advice if you have severe abdominal pain or no bowel movement despite treatment.

Evidence & guidelines

Stimulant laxatives such as senna are recommended by NICE for short-term and opioid-related constipation when first-line measures fail.

Reference: NICE CG190; RCOG obstetric pharmacology guidance; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.